A class of medications best known for treating diabetes and obesity may also reduce the risk of addiction—and help people who already have one, a new study shows.

A major new study reveals that older adults with cancer and type 2 diabetes who take GLP-1 receptor agonist medications (GLP-1RAs) experience significantly better overall survival rates compared to ...

A large study of US veterans suggests that diabetes and weight-loss medicines may curb cravings and lower severe addiction outcomes, though clinical trials are still needed.

A new study found that GLP1-RA medications may help lower the risk of a cardiovascular event in people with type 2 diabetes. Getty Images GLP-1 medications commonly prescribed for weight loss, like ...

Ozempic is intended to help people with diabetes manage blood sugar. A dietitian breaks down exactly what Ozempic is, and if ...

Type 2 diabetes occurs when the body does not use insulin effectively or does not produce enough insulin to maintain healthy blood sugar levels. Medications aim to lower blood glucose, reduce A1C, and ...

Excess body weight can raise the risk of certain cancers, leading researchers to wonder whether blockbuster drugs like Wegovy, Ozempic and Zepbound could play a role in cancer prevention. Now, a study ...

Pfizer has entered an agreement to license Sciwind Biosciences' type 2 diabetes treatment ecnoglutide, with potential payments ​of up to $495 million if milestones are ‌met, the Chinese drugmaker said ...

Popular drug class quiets "drug noise," says researcher ...

These findings position henagliflozin at the intersection of diabetes care and longevity science. They are raising both optimism and debate over whether existing medications might also serve as ...

Researchers from Queen Mary University of London have found that a medication originally developed for glycemic control can reverse serious heart damage—not by controlling blood sugar as originally ...